Yahoo Web Search

  1. Ads
    related to BRISTOL-MYERS SQUIBB COMPANY
  1. NASDAQ: AMGN) AstraZeneca plc (NYSE: AZN) Bristol-Myers Squibb Co (NYSE: BMY)( reported better-than-expected third-quarter results) Celgene Corporation (NASDAQ: CELG)(third-quarter ...

  2. Celgene Corporation CELG reported adjusted earnings of $2.99 per share in third-quarter 2019, which beat the Zacks Consensus Estimate of $2.73 and increased from $2.29 a year ago. Moreover, ...

  3. Pfizer PFE, Merck MRK, Bristol-Myers BMY, Sanofi SNY, Glaxo GSK and Bayer released their third-quarter results this week. In other important news, AstraZeneca’s first-line lung ...

  4. It’s worth keeping in mind that when companies incur a loss for a temporary period, they are valued on their revenues, as sales growth (or decline) is usually an indicator of a company ...

  5. How to Cash In When Firms Merge

    Kiplinger via Yahoo FinanceNov 01 15:53 PM

    Other big deals announced this year include Bristol-Myers Squibb's pending acquisition of Celgene, which S&P Global calculates is worth a whopping $95 billion, and United ...

  6. Bristol-Myers Squibb Company BMY announced that the FDA has accepted and granted priority review designation to a supplemental Biologics License Application (sBLA ...

  7. Economic Data Deluge

    Zacks via Yahoo FinanceOct 31 14:58 PM

    Click to get this free report Bristol-Myers Squibb Company (BMY) : Free Stock Analysis Report Royal Dutch Shell PLC (RDS.A) : Free Stock Analysis Report...

  8. Biotech ETFs in Focus on Impressive Q3 Earnings Results

    Zacks via Yahoo FinanceNov 04 22:05 PM

    The company slightly raised its previously issued sales guidance while lifting the earnings range significantly.

  9. A 52-week high generally serves as an indicator for investors as stocks near that level are perceived to be winners. Notably, investors often wonder if the stock is overpriced considering the high price.

  10. Myers Squibb said the decision meant it had all the needed regulatory approvals and would close the acquisition on Wednesday. Amgen has agreed to buy Celgene's Otezla business, ...

  1. Ads
    related to BRISTOL-MYERS SQUIBB COMPANY